Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies
Open Access
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 380 (2) , 586-597
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research Wales
This publication has 173 references indexed in Scilit:
- Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasisOncogene, 2012
- Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell SproutingJournal of Biological Chemistry, 2012
- Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9Angiogenesis, 2012
- Tumour vascularization: sprouting angiogenesis and beyondCancer and Metastasis Reviews, 2007
- A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7Breast Cancer Research and Treatment, 2006
- A Role for BMP Heterodimers in Roof Plate-Mediated Repulsion of Commissural AxonsNeuron, 2003
- Type I Collagen Induces Expression of Bone Morphogenetic Protein Receptor Type IIBiochemical and Biophysical Research Communications, 2001
- Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast CellsExperimental Cell Research, 2000
- Induction of Smad6 mRNA by Bone Morphogenetic ProteinsBiochemical and Biophysical Research Communications, 1998
- Potent Ectopic Bone-Inducing Activity of Bone Morphogenetic Protein-4/7 HeterodimerBiochemical and Biophysical Research Communications, 1995